Superior Molecular Structure Solves Linear Peptide Bottlenecks
Conventional linear peptides frequently suffer from protease degradation, poor skin penetration and short‑lived efficacy in cosmetic formulations. By forming closed covalent ring conformations, complex cyclic peptides gain higher structural rigidity, stronger anti‑degradation capacity and improved receptor‑binding affinity. Such molecular advantages allow sustained bioactivity on skin, lowering formulation barriers for high‑performance anti‑aging skincare raw materials.
Surging Domestic New‑Ingredient Registrations Drive Industrial Progress
From May to August 2026, multiple complex cyclic peptide candidates completed NMPA cosmetic new‑ingredient filings in China, including bicyclic hexadecapeptide‑1 and cyclohexapeptide‑120, contributed by local cosmetic and biotech enterprises. The revised new‑ingredient filing policy effective July 15 lowers partial compliance thresholds, further stimulating domestic cyclic‑peptide pipeline expansion and speeding up lab‑to‑market transformation of innovative sequences.
Manufacturing Scaling Remains Core Industry Challenge
Although complex cyclic peptides deliver outstanding performance, sophisticated cyclization synthesis procedures create cost and purification hurdles for mass production. Domestic raw‑material manufacturers are optimizing solid‑phase synthesis and biosynthetic routes to raise yields and cut unit costs. At present, high‑end complex cyclic peptides remain relatively high‑priced, restricting large‑volume adoption in mass‑market cosmetic product lines.
Future Trend: Cyclic Peptides Combined with Plant‑Derived Actives & Delivery Systems
Industry consensus indicates that innovation will shift from single cyclic‑peptide molecule development toward integrated solutions. Formulators increasingly match complex cyclic peptides with plant extracts and advanced nanocarrier delivery technologies to boost overall skin‑care performance. Such composite strategies help balance high efficacy, mildness and formulation compatibility for next‑generation anti‑aging cosmetic raw‑material portfolios.
